| USER TYPE | DEVICE RECOMMENDED |
| Individuals with problematic hypoglycemia (e.g., frequent/severe hypoglycemia, nocturnal hypoglycemia, hypoglycemia unawareness) | CGM devices with predictive alarms/alerts |
| Patients with newly diagnosed T2D, patients treated with non-hypoglycemic medications, patients who are at low risk for hypoglycemia, and patients who are motivated to scan their device several times per day | CGM devices without alarms/alerts |
| Patients preferring treatment with continuous subcutaneous insulin infusion (CSII) | Integrated CGM devices (iCGM) with the new insulin pumps/CGM-integrated automated insulin delivery (AID) insulin pump systems |
| Patients preferring treatment with multiple daily insulin injections (MDI) | New insulin ‘smart’ pens which accurately track dosages and injection times, and can be paired with one or more of the available CGM devices |
MAT-BH-2200913/V1/Nov 2022